远程医疗在风湿病患者中的应用:系统综述与研究议程建议
该系统综述检索了截至2016年4月的文献,筛选177篇后纳入23项研究(仅9项为随机对照试验),评估远程风湿病学的可行性、有效性和患者满意度。干预分为同步远程会诊与异步远程疾病活动评估、治疗监测、康复和自我管理项目,可行性及满意度普遍高或非常高,对照试验中有效性等于或高于面对面方式,但研究异质性大且存在小样本、缺乏盲法等局限。
要点
- 远程风湿病学干预在可行性及患者满意度方面普遍高或非常高。
- 对照试验中远程干预有效性等于或高于标准面对面方式。
- 现有随机对照试验仅9项,样本量小且缺乏盲法,证据质量有限。
核心结论
- 远程医疗可能为风湿病提供一种接受度良好的远程会诊、治疗和疾病活动监测方式。
- 需要更高质量的随机对照试验来证明不同远程风湿病学干预的有效性。
研究设计与样本
- 系统综述检索PubMed、Scopus和Cochrane数据库(2016年4月),使用远程医疗和风湿病的相关MeSH及关键词。
- 共筛选177篇文章,纳入23项研究,其中仅9项为随机对照试验。
- 采用Cochrane协作组偏倚风险评估工具和改良版CONSORT 2010声明进行方法学评价。
主要发现
- 5项研究报告可行性,14项报告有效性,9项报告患者满意度。
- 干预分为同步(远程会诊)和异步(远程疾病活动评估、治疗策略远程监测或康复、远程自我管理项目)两类。
- 7项研究(30.4%)为类风湿关节炎,2项(8.7%)为系统性硬化症(其中1项也纳入类风湿关节炎患者),5项(21.7%)为纤维肌痛,2项(8.7%)为骨关节炎,3项(13.0%)为幼年特发性关节炎,4项(17.4%)为混合疾病队列。
- 干预和结局的异质性阻碍了结果的荟萃分析。
- 对照试验中有效性等于或高于标准面对面方式,但这些试验受小样本量和缺乏参与者盲法影响。
关键数值与推荐
- 可行性及患者满意度在所有干预类型中均高或非常高。
- 对照试验中远程干预有效性等于或高于标准面对面方式,但受小样本量和缺乏盲法影响。
临床怎么用
- 远程医疗可用于风湿病患者的远程会诊、治疗和疾病活动监测。
- 远程干预在可行性和患者满意度方面表现良好,可考虑作为面对面诊疗的补充方式。
局限性
- 纳入研究仅9项为随机对照试验,且样本量小、缺乏参与者盲法。
- 干预和结局异质性大,无法进行荟萃分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically review the scientific literature regarding tele-rheumatology and draw conclusions about feasibility, effectiveness, and patient satisfaction. METHODS: PubMed, Scopus, and Cochrane database searches were performed (April 2016) using relevant MeSH and keyword terms for telemedicine and rheumatic diseases. Articles were selected if reporting outcomes for feasibility, effectiveness, and patient satisfaction and methodologically appraised using the Cochrane Collaboration's tool for assessing risk of bias and a modified version of CONSORT 2010 Statement. RESULTS: A total of 177 articles were screened, 23 were selected for the present review but only 9 were RCTs. Five studies reported on feasibility, 14 effectiveness, and 9 satisfaction rates for different tele-rheumatology interventions grouped in synchronous (remotely delivered consultation) and asynchronous (remote disease activity assessment; tele-monitoring of treatment strategies or rehabilitation; and remotely delivered self-management programs). Seven studies (30.4%) were on rheumatoid arthritis, 2 (8.7%) were on systemic sclerosis (1 including also rheumatoid arthritis patients), 5 (21.7%) on fibromyalgia, 2 (8.7%) on osteoarthritis, 3 (13.0%) on juvenile idiopathic arthritis and 4 (17.4%) on mixed disease cohorts. Interventions and outcomes heterogeneity prevented meta-analysis of results. Overall, feasibility and patient satisfaction rates were high or very high across intervention types. Effectiveness was equal or higher than standard face-to-face approach in controlled trials which, however, were affected by small sample size and lack of blinding participants according to appraisal tools. CONCLUSION: Telemedicine may provide a well-accepted way to remotely deliver consultation, treatment and monitoring disease activity in rheumatology. Higher quality RCTs demonstrating effectiveness of different tele-rheumatology interventions are needed.
引用
- Piga M, Cangemi I, Mathieu A, et al. Telemedicine for patients with rheumatic diseases: Systematic review and proposal for research agenda. Semin Arthritis Rheum. 2017. PMID: 28420491. doi:10.1016/j.semarthrit.2017.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。